Editor-Curated Robotics Industry Briefing - RobotToday

CorTec Secures Second FDA Breakthrough Device Designation for Brain Interchange BCI

CorTec has achieved a second Breakthrough Device Designation from the FDA for its Brain Interchange brain-computer interface, specifically for aiding communication in individuals with non-progressive quadriplegia. This designation allows users with paralysis in all four limbs to control a computer cursor using neural signals, facilitating independent interaction with digital systems. This development is significant as it highlights the potential of the Brain Interchange platform to serve dual purposes: as a therapeutic tool for stroke rehabilitation and as an assistive device for communication. The FDA's Breakthrough Device Designation is granted to technologies that promise more effective treatment for serious conditions, ensuring a streamlined regulatory review process. Looking ahead, CorTec is set to explore the communication capabilities of the Brain Interchange system under structured FDA engagement. The ongoing stroke study at the University of Washington has already shown promising results, with participants demonstrating computer control through thought, indicating the system's potential for enhancing the quality of life for individuals with severe mobility impairments.